Sentiment-Signal
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 18.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ange Act. ◻ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of C |
| 05.11.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | nge Act. ◻ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce |
Stammdaten
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.
Unternehmen & Branche
| Name | ACCENDRA HEALTH INC/VA/ |
|---|---|
| Ticker | ACH |
| CIK | 0000075252 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Distribution |
| SIC | 5047 · Wholesale-Medical, Dental & Hospital Equipment & Supplies |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 274,0 Mio. USD |
| Beta | 1,26 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 2,762,032,000 | -1,100,642,000 | -14.31 | 2,451,761,000 | -460,978,000 |
| 2025-09-30 | 10-Q | 697,264,000 | -150,276,000 | -1.94 | 4,036,226,000 | -429,507,000 |
| 2025-06-30 | 10-Q | 681,917,000 | -869,058,000 | -11.30 | 4,154,545,000 | -281,010,000 |
| 2025-03-31 | 10-Q | 2,632,048,000 | -24,982,000 | -0.32 | 4,856,424,000 | 570,979,000 |
| 2024-12-31 | 10-K | 2,680,112,000 | -362,686,000 | -4.73 | 4,656,156,000 | 586,364,000 |
| 2024-09-30 | 10-Q | 686,846,000 | -12,770,000 | -0.16 | 5,081,282,000 | 895,730,000 |
| 2024-06-30 | 10-Q | 660,401,000 | -31,913,000 | -0.42 | 5,304,004,000 | 881,840,000 |
| 2024-03-31 | 10-Q | 2,612,680,000 | -21,886,000 | -0.29 | 5,207,993,000 | 916,006,000 |
| 2023-12-31 | 10-K | 2,552,572,000 | -41,301,000 | -0.53 | 5,093,322,000 | 945,304,000 |
| 2023-09-30 | 10-Q | 2,591,742,000 | -6,426,000 | -0.08 | 5,124,063,000 | 886,860,000 |
| 2023-06-30 | 10-Q | 2,563,226,000 | -28,241,000 | -0.37 | 5,288,000,000 | 896,229,000 |
| 2023-03-31 | 10-Q | 2,522,849,000 | -24,418,000 | -0.32 | 5,310,203,000 | 924,400,000 |
| 2022-12-31 | 10-K | 9,955,475,000 | 22,389,000 | 0.29 | 5,386,283,000 | 966,742,000 |
| 2022-09-30 | 10-Q | 2,497,401,000 | 12,497,000 | 0.16 | 5,538,582,000 | 966,837,000 |
| 2022-06-30 | 10-Q | 2,500,015,000 | 28,604,000 | 0.37 | 5,555,278,000 | 958,659,000 |
| 2022-03-31 | 10-Q | 2,406,952,000 | 39,279,000 | 0.52 | 5,707,969,000 | 947,622,000 |
| 2021-12-31 | 10-K | 9,785,315,000 | 221,589,000 | 2.94 | 3,536,551,000 | 938,501,000 |
| 2021-09-30 | 10-Q | 2,502,175,000 | 44,129,000 | 0.58 | 3,584,119,000 | 887,005,000 |
| 2021-06-30 | 10-Q | 2,489,460,000 | 65,896,000 | 0.87 | 3,591,829,000 | 848,019,000 |
| 2021-03-31 | 10-Q | 2,326,534,000 | 69,589,000 | 0.98 | 3,390,821,000 | 786,261,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-08-14 | Coliseum Capital Management, LLC | 10% Owner | Open Market Purchase | 492,852 | 5.31 | 2,617,044.12 | +96,9% | |
| 2025-08-13 | Coliseum Capital Management, LLC | 10% Owner | Open Market Purchase | 325,000 | 5.46 | 1,774,500.00 | +65,7% | |
| 2025-08-12 | Coliseum Capital Management, LLC | 10% Owner | Open Market Purchase | 720,000 | 5.15 | 3,708,000.00 | +137,3% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.